Amcor launches new lidding for combination products

Amcor, a developer and producer of responsible packaging solutions, has launched a proprietary healthcare lidding technology that will be utilised for combination products – those consisting of two or more regulated components (device, drug or biologic).

This latest innovation from Amcor is based on a patented inert film development and laminate design. It provides a lidding solution that can withstand heat sterilisation, the process of preserving and sterilising items, while preventing drug uptake into the packaging. The packaging solution can combine healthcare products, such as devices with an Active Pharmaceutical Ingredient (API) that forms the basis of a medicine. It ensures machinability, integrity after sterilisation, as well as a convenient peel opening for patients. The features of the new product complement Amcor’s existing healthcare portfolio, which range from lidding for demanding sterilisation environments to high barrier overwraps protecting eye droppers and medications for the eye. 

Amcor collaborated with Johnson & Johnson Vision over the course of several years to develop the lidding technology for use with contact lenses. Each company contributed specific skills and perspective, notably Amcor’s expertise with film extrusion, lamination and conversion for healthcare, and J&J Vision’s expertise on ophthalmic device packaging requirements. 

Peter Konieczny, Amcor’s chief commercial officer said: “We are bringing together industry-leading innovation and close customer relationships to develop the packaging solutions of the future. With this next-generation healthcare lidding technology we are opening a world of possibilities for products using active pharma ingredients. We look forward to extending this differentiated lidding technology to additional combination products in the future.”